Mesa Laboratories Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 48/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 95.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Mesa Laboratories Inc's Score
Industry at a Glance
Industry Ranking
48 / 207
Overall Ranking
148 / 4563
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
3
analysts
Buy
Current Rating
95.000
Target Price
+21.84%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Mesa Laboratories Inc Highlights
StrengthsRisks
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Fairly Valued
The company’s latest PE is -259.61, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.12M shares, decreasing 12.36% quarter-over-quarter.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Ticker SymbolMLAB
CompanyMesa Laboratories Inc
CEOOwens (Gary M)
Websitehttps://mesalabs.com
FAQs
What is the current price of Mesa Laboratories Inc (MLAB)?
The current price of Mesa Laboratories Inc (MLAB) is 80.470.
What is the symbol of Mesa Laboratories Inc?
The ticker symbol of Mesa Laboratories Inc is MLAB.
What is the 52-week high of Mesa Laboratories Inc?
The 52-week high of Mesa Laboratories Inc is 155.120.
What is the 52-week low of Mesa Laboratories Inc?
The 52-week low of Mesa Laboratories Inc is 55.450.
What is the market capitalization of Mesa Laboratories Inc?
The market capitalization of Mesa Laboratories Inc is 443.45M.
What is the net income of Mesa Laboratories Inc?
The net income of Mesa Laboratories Inc is -1.97M.
Is Mesa Laboratories Inc (MLAB) currently rated as Buy, Hold, or Sell?
According to analysts, Mesa Laboratories Inc (MLAB) has an overall rating of Buy, with a price target of 95.000.
What is the Earnings Per Share (EPS TTM) of Mesa Laboratories Inc (MLAB)?
The Earnings Per Share (EPS TTM) of Mesa Laboratories Inc (MLAB) is -0.310.